The efficacy and safety of denosumab in postmenopausal women with osteoporosis previously treated with bisphosphonates: A review

ConclusionThe outcomes and treatment compliance were improved in postmenopausal osteoporotic women who shifted to denosumab from bisphosphonates.The translational potential of this articleThe replacement of bisphosphonates with denosumab may lead to better therapeutic efficacy and fewer adherence barriers ​than those with continued usage of bisphosphonates, which in the future may guide the choice of drug therapy in clinics.
Source: Journal of Orthopaedic Translation - Category: Orthopaedics Source Type: research